Martin Aaron 4

What Happened
Martin Aaron, President, Medicare Advantage at Humana Inc., received an award of 8,206 shares on May 1, 2026. The shares were reported at $0.00 per share (total reported value $0), indicating an equity grant/award rather than a market purchase. The transaction is coded as an "A" (award/grant).

Key Details

• Transaction date: 2026-05-01; Filing date: 2026-05-05 (filed on the SEC Form 4; timely — within the two-business-day window).
• Transaction type/code: Award/Grant (A). Price: $0.00. Shares acquired: 8,206. Reported cash value: $0.
• Holdings after transaction: filing did not list a total common-share count after this grant in the provided excerpt.
• Footnote: Filing notes inclusion of 25,237 restricted stock units (RSUs) that represent contingent rights to receive one share each; these RSUs are exempt under Rule 16b-3(d)(1) & (3) under Humana’s 2019 Amended & Restated and 2026 Stock Incentive Plans.
• No 10b5-1 plan, tax-withholding sale, or immediate sale was reported for these shares.

Context
This was a compensation-related equity grant (RSUs/awarded shares). Grants at $0 are common for executive compensation and typically vest over time per a plan schedule; they do not reflect an open-market purchase or sale and therefore are not a direct bullish/sell signal. The RSUs noted in the footnote are contingent rights to future shares and are treated differently under SEC rules (exempt per the cited plan provisions).